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Abstract 
Background: Previous studies have shown that DNA methylation (DNAm) is associated with body mass index (BMI). 
However, it is unknown whether DNAm at pre-adolescence is associated with BMI status transition from pre- to post-
adolescence. In the Isle of Wight (IoW) birth cohort, genome-wide DNA methylation in whole blood was measured 
using Illumina Infinium Human450 and EPIC BeadChip arrays in n = 325 subjects, and pre- to post-adolescence BMI 
transition was classified into four groups: (1) normal to normal, (2) normal to overweight or obese, (3) overweight or 
obese to normal, and (4) persistent overweight or obese. We used recursive random forest to screen genome-wide 
Cytosine-phosphate-Guanine (CpG) sites with DNAm potentially associated with BMI transition for each gender, and 
the association of BMI status transition with DNAm at an earlier age was assessed via logistic regressions. To evaluate 
gender specificity, interactions between DNAm and gender were included in the model. Findings in the IoW cohort 
were further tested in an independent cohort, the Avon Longitudinal Study of Parents and Children  (ALSPAC).
Results: In total, 174 candidate CpGs were selected including CpGs from screening and CpGs previously associated 
correctionally with BMI in children and adults. Of these 174 CpGs, pre-adolescent DNAm of 38 CpGs in the IoW cohort 
was associated with BMI status transition, including 30 CpGs showing gender-specific associations. Thirteen CpGs 
showed consistent associations between the IoW cohort and the ALSPAC cohort (11 of which were gender-specific).
Conclusion: Pre-adolescence DNAm is associated with the change in BMI status from pre- to post-adolescence and 
such associations are likely to be gender-specific.
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Introduction
Adolescence, marked by onset of physiologically normal 
puberty between the ages of 10 and 19, is a transition 
phase of growth and development between childhood 
and adulthood [1]. During growth and maturation, body 
composition changes may be accompanied by dramatic 
changes in body mass index (BMI) and development 
of obesity [2–4]. In US children, the average BMI is 
16.0 kg/m2 at age 6 to 7 years, but by 16–17 years of age, 
average BMI is close to 22  kg/m2 [4, 5]. A recent study 
showed a significant increase in BMI among males from 
age 12 to 19  years, but not among other age groups or 
among females [6]. In addition, national longitudinal data 
collected from US adolescents enrolled in wave II (1996) 
and wave III (2001) of the National Longitudinal Study of 
Adolescent Health showed that there was a high propor-
tion of adolescents becoming and remaining obese into 
adulthood during a 5-year transition period between 
adolescence and young adulthood [7].
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Both environmental [8–10] and genetic factors have 
been found to affect BMI and BMI change [11, 12]. The 
role of genetic and environmental factors interaction 
suggests that other gene regulatory mechanisms, such 
as epigenetic mechanisms, DNA methylation (DNAm) 
in particular, reflecting memory of past exposure or 
changes at different stages of life [13], may act as an 
interface between environment exposure and genetics. 
Various studies have contributed to the understanding 
of underlying epigenetic mechanisms or explore epige-
netic markers of obesity or BMI. DNAm at certain CpG 
sites has been found to be associated with BMI during 
adolescence [14]. In an epigenome-scale study, DNAm 
at cg22891070 was shown to be inversely associated with 
expression of HIF3A in adipose tissue [15]. Recent meta-
analyses also identified 187 CpG sites where DNAm was 
associated with BMI in adults [16] and 10 CpGs in chil-
dren (age 2–10) and 1 CpG in adolescents (age 12–18) 
[17]. All these studies focused on the association between 
DNAm and BMI cross-sectionally at a single time point. 
DNAm reflects past environmental exposure, and thus 
potentially is on the casual pathway between early life 
environmental exposure and development of obesity in 
adolescence. Detecting early age epigenetic markers for 
BMI status change may benefit obesity early prevention 
and intervention. In this study, we hypothesized that at 
specific CpG sites, DNAm at an earlier age was associ-
ated with BMI status transition later in life.
Results
In total, 325 children with BMI and DNAm available at 
both ages 10 and 18 years were included in the analyses. 
Among these 325 children, n = 186 (57.2%) were male 
(Table 1). Average ZBMIs and distribution of BMI status 
transitions for each gender were not statistically different 
from those in the complete cohort (p value > 0.05).
Assessment of BMI status transition at previously identified 
BMI‑associated CpGs
Of the 187 CpGs associated with BMI in adults in the 
study of Wahl et  al. [16], 178 CpGs were available in 
the IoW cohort. Via linear mixed models, at 158 CpGs 
(88.8%), the associations of DNAm at age 10 years with 
BMI at 10 and 18 years in the IoW cohort had the same 
direction as those in Wahl et al. [16], and at 64 of these 
CpGs [see Additional file 1], the associations were statis-
tically significant at the 0.05 level. These 64 CpGs from 
the Wahl et al.’s study [16], along with 10 of the 11 identi-
fied CpGs in Vehmeijer et al.’s study [17] (DNAm at 10 of 
the 11 CpGs were available in IoW), were further exam-
ined separately for their associations with BMI status 
transition across adolescence. There were no common 
CpGs between the 64 CpGs and the 10 CpGs.
Using a FDR = 0.05, one of the 64 CpG sites associated 
with cross sectional BMI in the IoW cohort was associ-
ated with BMI status transition across adolescence using 
logistic regressions; a higher methylation of cg07728579 
in gene FSD2 was associated with a higher odds of 
being in the transition from overweight / obese to nor-
mal group irrespective of gender (log odds ratio [log-
OR] = 5.00, p value 3.38 ×  10–4, Table 2). None of these 64 
CpGs showed interaction effects with gender. Of the 10 
CpGs that were identified in Vehmeijer et al.’s study [17], 
one CpG showed a statistically significant DNAm × sex 
interaction effect on BMI status transition across adoles-
cence in the IoW cohort; at cg15125798, boys with higher 
DNAm were more likely to be in the transition group 
from normal weight to overweight or obese, but for girls, 
the association was in the opposite direction (p value for 
interaction effect: 2.3 ×  10–3, Table 3).
Assessment of BMI status transition at candidate CpGs 
identified via recursive Random Forest
In total, 100 of the 439,586 CpGs were selected based on 
results from the recursive random forest machine-learn-
ing technique based on non-parametric associations of 
DNAm at age 10 years with BMI status transition. After 
controlling FDR = 0.05, at 36 of these 100 CpGs, DNAm 
at ages 10 years was significantly associated with BMI sta-
tus transition from 10 to 18 years of age. These 36 CpGs 
included 8 CpGs where the association was gender inde-
pendent, and 29 CpGs (with one CpG site, cg16460342, 
Table 1 Comparison between subsamples and complete 
samples in the IoW
* Subset samples are selected based on availability of DNA methylation data. ** 
OwO: Overweight/Obese
Subset sample 




ZBMI (Mean ± SD)
Age10 0.45 (1.04) 0.29 (0.92) 0.45
Male 0.43 (1.01) 0.18 (0.92) 0.43
Female 0.49 (1.09) 0.39 (0.91) 0.49
Age18 0.53 (1.17) 0.20 (1.01) 0.53
Male 0.41 (1.16) −0.03 (1.05) 0.41
Female 0.69 (1.18) 0.41 (0.93) 0.69
N (%)
Gender
Male 186 (57.2%) 382 (47.4%) 0.43
Female 139 (42.8%) 424 (52.6%)
BMI transition
Normal → OwO** 31 (10.8%) 68 (9.8%) 0.9
OwO → Normal 24 (8.3%) 66 (9.5%)
OwO → OwO 30 (20.4%) 81 (11.7%)
Normal → Normal 203 (70.5%) 479 (6.9%)
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also among the 8 main-effect-only CpGs) with gender-
specific associations.
Among the 8 CpG sites with DNAm at age 10  years 
associated with the transition of BMI status between 
10 and 18 (Table 2), regardless of gender, at 5 CpG sites 
(Table 2), subjects with higher DNAm were more likely to 
be in the transition to normal group (from obese or over-
weight to normal. The estimated log-OR were all > 2 with 
p values ≤ 2 ×  10–3. Table  2). At the other 3 CpGs, pre-
adolescence DNAm was associated with transition from 
overweight/obese to normal but in an opposite direction 
compared to the aforementioned 5 CpGs (cg16460342, 
log-OR = -3.63, p value = 0.002) or with transition from 
normal weight to obese or overweight (cg14062083 and 
cg17866181, p value < 3 ×  10–4. Table 2).
Statistically significant interaction effects were iden-
tified between DNAm at age 10 and BMI status transi-
tion across adolescence at 29 CpG sites (Table 3). At 10 
of these 29 CpGs, DNAm at age 10 years was associated 
with the persistence of overweight/obesity across ado-
lescence, and the associations were opposite between 
boys and girls. Specifically, at 4 CpGs, for girls, subjects 
with higher DNAm were more likely to have persis-
tent obese or overweight, but for boys, the associations 
were in the opposite direction (p values for interaction 
effects < 5 ×  10–3). At the other 6 CpGs (Table 3), a higher 
DNAm was associated with higher odds of being persis-
tent obese or overweight for boys but the opposite direc-
tion of associations was observed for girls (p values for 
interaction effects < 0.002).
DNAm at 16 of the 29 CpGs showed statistically sig-
nificant gender-specific associations with BMI status 
transition from normal weight to overweight or obese 
(Table 3). At 7 of these 16 CpG sites, among girls, higher 
DNAm at age 10 years was associated with higher odds 
of becoming overweight or obese in adolescence, but 
for boys, the association was opposite (p values for 
interaction effects < 8 ×  10–3. Table  3). At the remain-
ing 9 of the 16 CpG sites, girls with higher DNAm at age 
10  years were less likely to be in the transition to over-
weight or obesity group, but for boys the transition was 
more likely (p values for interaction effects < 6 ×  10–3). 
For the remaining three of the 29 CpGs (cg11249998, 
cg15708019, cg14260083), DNAm at age 10 years showed 
gender-specific associations with BMI status transition 
from being overweight or obese to normal weight (all p 
values < 4 ×  10–4. Table 3).
Replication in ALSPAC
The 38 CpG sites associated with BMI status transition 
across adolescence (including one CpG from Wahl et al. 
[16], one from Vehmeijer et al. [17], and 36 from the can-
didate CpGs using epigenome-wide screening in the IoW 
cohort) were further assessed in the ALSPAC cohort. 
Consistent regression coefficients that were statisti-
cally significant or marginally significant at the 0.05 level 
were shown in 2 of the 38 CpGs in ALPSAC, including 
one gender-unspecific CpG site cg16460342 (P2RX4, p 
value = 0.07), and one gender-specific CpG, cg14260083 
(RADIL, p value = 0.04). Compared to other CpG sites, 
larger interaction effects were observed in both cohorts 
at cg14260083; girls with a higher level of DNAm at 
this CpG site were less likely in the transition to normal 
weight group, but boys were more likely to be in this 
group if they had a higher level of DNAm (Table  3). In 
addition, although not statistically significant, at another 
Table 2 Effects of DNAm on BMI status transition (irrespective to gender) during adolescence
In total, 9 CpG sites were identified in the IoW cohort, which were further tested in the ALSPAC cohort. Results in bold font denote that the estimated regression 
coefficients are in the same direction between the two cohorts
* OwO means Overweight/Obese. Est.: Estimate of regression coefficients.  praw: raw p value.  pFDR: FDR-adjusted p value. # Gene CD82 was identified using SNIPPER
Name 10–18 years (IoW) 7–15 years (ALSPAC)
Est.* praw* PFDR* Est praw Gene name Gene’s location
Transition from Normal to OwO*
cg14062083 6.49 1.29 ×  10–4 0.01 – – KRTAP13-4 1stExon
cg17866181 −2.94 2.76 × 10–4 0.01 −0.05 0.76 BC036251 Body
Transition from OwO to Normal
cg02906784 4.95 2.33 ×  10–4 0.02 −0.56 0.31 CACNA2D3 Body
cg07728579 5.00 3.38 ×  10–4 0.02 −0.33 0.50 FSD2 TSS500
cg18935453 5.08 5.79 ×  10–4 0.02 – – LRP5 Body
cg23664926 2.76 7.16 ×  10–4 0.02 −0.11 0.72 CD82# –
cg10320997 3.83 9.97 ×  10–4 0.02 −0.17 0.67 SYNPO2 TSS1500
cg02382044 2.30 0.002 0.04 −0.44 0.20 TMOD3 TSS1500
cg16460342 −3.63 0.002 0.04 −0.65 0.07 P2RX4 Body
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11 of the 38 CpGs, consistent directions of associations 
were observed either in main effects (Table 2) or in inter-
action effects (Table 3). Thus, in total at 13 of the 38 CpG 
sites, consistent associations were observed between the 
two cohorts, IoW and ALSPAC.
Pathway analysis
In total, 13 CpGs showed consistent effects between the 
IoW and ALSPAC cohorts. The 13 CpGs were mapped to 
14 genes in total (Tables 2 and 3). Six pathways and eight 
processes were detected using ToppFun after controlling 
FDR of 0.05 with pathways involving at most 2000 genes. 
Among the 14 genes, eight genes were present in these 
pathways or processes, including FLNB, LYNX1, P2RX4, 
RADIL, WDR19, and three genes in the PCDHG family 
(Table 4).
Biological relevance assessment
For the 13 CpG sites showing consistent associations 
between IoW and ALSPAC cohorts, expression data at 7 
mapped genes (corresponding to 6 CpGs) were available. 
At 4 of the 6 CpGs, the association of DNAm with expres-
sion of their mapped genes was statistically significant or 
marginally significant at a significance level of 0.05. Fur-
thermore, at 3 of those 4 CpGs, DNAm was inversely 
correlated with expression of genes; for instance, at 
cg00283283 (on gene PCDHGA6), the Spearman’s cor-
relation coefficient is ρ = −0.269 (p value = 0.001), indi-
cating higher DNAm was associated with lower gene 
expression (Table 5).
Discussion
The aim of this study was to examine the association of 
pre-adolescent DNAm with BMI status transition dur-
ing adolescence. Among the 38 CpGs identified in the 
IoW cohort, consistent associations were observed in the 
ALSPAC cohort at 13 CpGs and in 11 of these 13 CpGs, 
the associations were gender specific. In two of the 13 
CpGs (cg16460342 in the body of P2RX4 and cg14260083 
in the body of RADIL), the associations (main effects or 
interaction effects) were statistically significant or mar-
ginally significant in both cohorts. Most of the CpGs (4 of 
6 CpGs) included in the assessment for their association 
with gene expression indicated a potential of biological 
relevance.
Among the pathways identified, although not all the 
identified pathways or biological processes are involved 
in the development of obesity, several pathways or pro-
cesses drew our attention. In the pathway of elevation of 
cytosolic Ca2 + levels and platelet calcium homeostasis, a 
recent study indicated that inflammation, either induced 
by cytokine exposure in vitro or by obesity in vivo, led to 
increased expression and activity of IP3Rs in adipocytes 
in a JNK-dependent manner and then increased cyto-
solic Ca2 + and impaired insulin action [18]. Another 
study also showed that weight loss restored SERCA3 
activity and subsequent calcium signaling, αIIbβ3 acti-
vation, platelet aggregation, and ADP secretion [19]. In 
the pathway of antiviral mechanism by IFN-stimulated 
genes ISG15 antiviral mechanism, interferons activated 
JAK–STAT signaling, which led to the transcriptional 
induction of hundreds of IFN-stimulated genes (ISGs). 
The ISG proteins generated by IFN pathways included 
direct effectors which inhibit viral infection through 
diverse mechanisms as well as factors that promote adap-
tive immune responses [20]. Antiviral interferons (IFNs), 
as key immune regulators against viral infections and in 
autoimmunity, emerged to be a pivotal player in the regu-
lation of adipogenesis [21]. In addition, for the GO bio-
logical process of cell adhesion, a recent study found that 
LSECs were involved in obesity-associated accumulation 
of myeloid cells via VLA-4-dependent cell–cell adhesion 
[22]. A better understanding of these pathways and pro-
cesses from the epigenetic perspective may benefit obe-
sity prediction and prevention at an earlier age.
The eight genes present in the identified pathways or 
biological processes include P2RX4 and RADIL, both 
these genes have been shown to be associated with obe-
sity or BMI. Gene P2RX4 is a protein coding gene and 
the receptor P2X4 can be found in uterine endometrium 
and fat cells, and in the smooth muscle of arteries [23]. 
Obesity is characterized by immune cell infiltration and 
inflammation. A recent study by Ruíz-Rodríguez et  al. 
shows that an increase in P2XR receptor expression could 
be associated with a progression in the metabolic state 
and the progression in the metabolic state is associated 
with an increase in BMI [24]. Rather than looking at one 
time point, our study focused on BMI status transition. 
Together with findings in Ruiz-Rodriguez et al. [24], our 
results from epigenetic and gene expression analyses sup-
ported that subjects with lower DNAm at cg16460342 on 
P2RX4 at pre-adolescence are more likely to experience 
a transition from normal weight to overweight or obese, 
rather than stay at normal weight through adolescence.
DNAm of cg14260083 on gene RADIL showed a 
gender-specific association with BMI status transition 
accompanied by large interaction effects observed in 
both IoW and ALSPAC cohorts. For females, our study 
showed that subjects with increased DNAm at this CpG 
site were less likely to be in the transition from over-
weight or obese to normal group, but for males, they were 
more likely. Evidence is limited on the direct connection 
between RADIL and BMI or obesity, but an earlier study 
demonstrated that gene RADIL was significantly asso-
ciated with birthweight [25] and birth weight has been 
shown to be linked to obesity [26, 27]. Gender-specific 
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effects of an epigenetic site in gene RADIL on BMI status 
transition as shown in our study have not been discussed 
in the literature.
The two genes (P2RX4 and RADIL), identified in the 
IoW and further confirmed in the ALSPAC, had some 
limited evidence of connections with BMI or obesity as 
discussed above. Although further investigation may be 
needed, the limited findings of these genes on their con-
nection with BMI implies that the underlying epigenetic 
mechanisms associated with BMI and those linked to 
BMI status transition were likely to be different. Con-
sequently, our findings indicate that the identified two 
CpGs on these two genes are likely to be informative 
biomarkers for BMI status transition during adolescence. 
For their potential to behave as causality epigenetic 
markers, further in-depth assessment is warranted.
It is worth noting that among the 74 candidate CpGs 
selected from Wahl et al. [16] and Vehmeijer et al. [17], 
only 2 CpGs (2.7%) were shown to be associated with 
BMI status transition in the IoW cohort. This is as 
expected. Both the studies of Wahl et al. and Vehmeijer 
et  al. (the assessment in children) were cross sectional 
and, as such, the methylation of CpGs identified is more 
likely to be a consequence of BMI change, as shown in 
both studies. The present study, in contrast, aimed to 
identify potential early epigenetic markers for future BMI 
status change. Thus, the findings from our study did not 
conflict with those in Wahl et al. [16] and Vehmeijer et al.
[17]; we examined the connection of DNAm with BMI-
related outcomes (i.e., BMI status change) from a dif-
ferent angle. We would like to point out, however, that 
there is a possibility that our identified CpGs were due 
to methylation quantitative trait loci (methQTLs), which 
deserves further assessment.
Gender-specificity in the associations of pre-adoles-
cence DNAm with BMI status transition was observed 
in most identified CpGs. At 13 CpGs showing consistent 
associations between the IoW cohort and the ALSPAC 
cohort, gender-specificity was shown at 11 of the 13 
CpGs (> 80%), indicating a possibility of different epige-
netic driving factors of BMI status transition between 
males and females. It is worth noting that these 13 CpGs 
represent a relatively small portion (~ 30%) of CpGs 
Table 4 Biological pathways/processes on genes with CpGs showing consistent interaction effects between IoW and ALSPAC
* The p values are multiple testing adjusted by controlling a false discovery rate of 0.05
Gene Source p values*
Pathways Pathways
P2RX4 REACTOME Elevation of cytosolic Ca2 + levels 9.521 ×  10–3
Platelet calcium homeostasis 1.730 ×  10–2
WDR19 Intraflagellar transport 2.283 ×  10–2
FLNB Antiviral mechanism by IFN-stimulated genes 4.251 ×  10–2
ISG15 antiviral mechanism 4.251 ×  10–2
FLNB KEGG Salmonella infection 4.737 ×  10–2
GO biological processes
WDR19 Myotome development 1.588 ×  10–3
Ciliary receptor clustering involved in smoothened signaling 
pathway
1.588 ×  10–3
PCDHGB5, PCDHGC3, PCDHGA6, RADIL Cell adhesion 1.718 ×  10–3
P2RX4 Positive regulation of microglial cell migration 1.984 ×  10–3
Sensory perception of touch 2.381 ×  10–3
Regulation of microglial cell migration 2.777 ×  10–3
P2RX4, LYNX1 Chemical synaptic transmission, postsynaptic 2.589 ×  10–3
FLNB Cytoskeletal anchoring at plasma membrane 4.756 ×  10–3
Table 5 Correlation between DNAm and gene expression for 
CpGs showing associations consistent between the IoW and 
ALSPAC cohorts
Only CpGs with available expression data of their mapped genes are included 
in the table
* Results in bold font had p value < 0.05, and those underlined had p value close 
to 0.05
CpG sites Gene Correlation p values*
cg16460342 P2RX4 0.208 0.014
cg00283283 PCDHGC3 −0.034 0.690
PCDHGA6 −0.269 0.001
cg15511327 LYNX1 −0.156 0.066
cg07719077 KIAA1211 −0.166 0.051
cg00331210 NARFL −0.013 0.883
cg04120329 PRAP1 0.084 0.324
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identified in the IoW cohort. It was noted that ZBMIs 
in males and females disagreed on average between the 
two cohorts for each gender (Additional file 2). In addi-
tion, DNA methylation in the IoW cohort was measured 
at ages 10 and 18 years, while in the ALSPAC cohort, the 
ages are 7 and 15 or 17 years. At the age of 15 years, chil-
dren might be still undergoing adolescence transition. All 
these might have influenced the degree of consistency 
in findings between the two cohorts. Further large-scale 
epigenetic studies are warranted to thoroughly evaluate 
the findings and establish their validity.
Conclusion
In conclusion, we demonstrate that DNAm at pre-adoles-
cence is associated with BMI status transition from pre- 
to post-adolescence and the associations are likely to be 
gender-specific. The identified CpGs have the potential 
to serve as candidate epigenetic factors in future stud-
ies with focus on epigenetic mechanisms of obesity in 
adolescence.
Methods
Study population, the Isle of Wight cohort
An unselected whole population birth cohort study was 
established in 1989/1990 on the Isle of Wight (IoW), UK 
[28]. After exclusion of adoptions, perinatal deaths and 
refusal for follow-up, 1,456 were enrolled and the study 
collected children’s information at ages 1 or 2, 4, 10, 18, 
and 26 years. The study was approved by the Isle of Wight 
Local Research Ethics Committee, and written informed 
consent was obtained from parents, participants, or both. 
Data from participants with measurements of height 
and weight at both ages, puberty onset age, and personal 
smoking status were collected. BMI z-scores (ZBMI) 
were calculated based on the British standards [29] for 
children at ages 10 and 18 years.
DNA methylation (DNAm)
DNA was extracted from whole blood samples collected 
at ages 10 and 18 years using a standard salting out pro-
cedure [30]. DNAm was measured using the Illumina 
Infinium HumanMethylation450 and MethylationE-
PIC Beadchips (henceforth will be denoted as 450 k and 
EPIC, respectively) (Illumina, Inc., San Diego, CA, USA), 
which interrogate > 484,000 and > 850,000 CpG sites, 
respectively. Data pre-processing was undertaken using 
the CPACOR pipeline [31]. Briefly, intensity values were 
background corrected and assessed for quality. Probes 
not reaching a detection p value of 10−16 in at least 95% of 
samples were excluded. The data were quantile normal-
ized using the R package, minfi [32]. Autosomal probes 
were then extracted and methylation level was converted 
to β values. Principal components (PCs) inferred based 
on control probes were used to represent latent chip-to-
chip and technical variations. Since DNAm data were 
from two different platforms, we determined the PCs 
based on DNAm at shared control probes. In total, 195 
control probes were shared between the two arrays and 
used to calculate the control probe PCs with the top 15 
to represent latent batch factors [33]. CpG sites common 
between the Illumina 450  k and EPIC platforms were 
included in this study. To reduce the potential influence 
of probe SNPs, CpG sites were further excluded if a SNP 
was within 10 base pairs of the targeted CpG site and if 
the minor allele frequency in the Caucasian population 
was > 7%. After pre-processing, in total, 439,586 CpGs 
were included for analyses.
Blood is a mixture of functionally and developmentally 
distinct cell populations [34] and adjusting for cell-type 
compositions removes potential confounding effects of 
cell heterogeneity in DNAm in blood samples [35]. Cellu-
lar composition of the blood sample was calculated using 
function estimateCellCounts in the R package minfi [36, 
37]. The proportions of six cell types, CD8T, CD4 + T 
cells, natural killer cells, B cells, monocytes, and granu-
locytes cells were estimated. At each of the 439,586 CpG 
sites, logit transformed DNAm at base 2 was regressed 
on the 15 PCs and the proportions of the cell types 
(except for CD8T to avoid collinearity), and the residuals 
were batch- and cell type-adjusted DNAm, for inclusion 
in subsequent analyses.
Genome‑wide RNA‑seq gene expression data generation
Gene expression levels from peripheral blood samples 
collected at 26 years from the IOWBC were determined 
using paired-end (2 × 75  bp) RNA sequencing with the 
Illumina Tru-Seq Stranded mRNA Library Preparation 
Kit with IDT for Illumina Unique Dual Index (UDI) bar-
code primers following the manufacturer’s recommen-
dations. All samples were sequenced twice using the 
identical protocol, and for each sample, the output from 
both runs was combined. FASTQC were run to assess the 
quality of the FASTQ files (https:// www. bioin forma tics. 
babra ham. ac. uk/ proje cts/ fastqc/). Reads were mapped 
against Human Genome (GRch37 version 75) using 
HISAT2 (v2.1.0) aligner [34]. The alignment files, pro-
duced in the Sequence Alignment Map (SAM) format, 
were converted into the Binary Alignment Map (BAM) 
format using SAMtools (v1.3.1) [35]. HTseq (v0.11.1) was 
used to count the number of reads mapped to each gene 
in the same reference genome used for alignment [36]. 
Normalized read count FPKM (Fragments Per Kilobase 
of transcript per Million mapped reads) were calculated 
using the countToFPKM package (https:// github. com/ 
AAlhe ndi17 07/ count ToFPKM), and the log-transformed 
values were used for data analysis. In this study, RNAseq 
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gene expression data of n = 304 subjects with DNAm at 
age 10 years also available were included in the analyses 
for biological relevance at identified CpG sites.
Statistical analysis
The study samples were compared with the whole cohort 
using one sample t-tests for continuous variables, one 
sample proportion tests for percentages, and Chi-square 
tests for categorical variables. A p value < 0.05 was con-
sidered as being statistically significant. To identify can-
didate CpG sites potentially associated with BMI status 
transition, two approaches were used: assessment of pre-
viously identified BMI-associated CpG sites, and epige-
nome-wide screening in the IoW cohort.
Previously identified BMI‑associated CpG sites
In a previous epigenome-wide association study (EWAS) 
of 5387 individuals in multiple cohorts, Wahl et al. [16] 
identified DNAm of 187 CpGs associated with BMI in 
adults (mean age > 50  years). To assess the longitudinal 
relationship between each of these CpGs and BMI in ado-
lescents in the IoW cohort with random subject effects 
addressed, linear mixed models were implemented in 
which DNAm at ages 10 and 18  years was the depend-
ent variable and BMI at ages 10 and 18 years, gender and 
exposure to smoke evaluated at ages 10 and 18 years were 
independent variables. Those CpG sites associated with 
BMI in the IoW cohort (p value < 0.05) were used in sub-
sequent analyses to examine their association with BMI 
status transition across adolescence. In another EWAS 
assessment with 4133 children from 23 studies, Vehmei-
jer et at. [17] identified 11 CpGs that associated with BMI 
in the age from 2 to 18  years based on cross-sectional 
analyses. We also included these 11 CpGs in our study 
and assessed their association with BMI status transition.
Epigenome‑wide CpG screening in the IoW cohort
A recursive random forest [38, 39] algorithm in the R 
package RandomForest was applied to screen CpG sites 
where DNAm at age 10 years was associated with ZBMI 
status transition from ages 10 to 18  years at each gen-
der. CpGs that passed screening were included in subse-
quent analyses. For each gender, the top 50 CpG sites that 
reduced the mean Gini indices to the maximum extent 
were included in subsequent analyses.
DNAm at pre‑adolescence with BMI status transition 
during adolescence
BMI status transition was defined based on ZBMIs. A 
child with ZBMI ≥ 2 was considered obese, between 
1.333 and 2 overweight, between −2.667 and −2 thin-
ness, and ≤ -2.667 severe thinness. Otherwise, the child’s 
BMI was regarded as being in the normal range. Four 
BMI transition statuses between ages 10 and 18  years 
were examined in our study: (1) normal to normal, (2) 
transition from normal to overweight or obese, (3) transi-
tion to normal defined as changing from overweight or 
obesity to normal, and (4) persistence defined as subjects 
persistently overweight or obese from pre- to post-ado-
lescence. Logistic regressions were applied to evaluate 
the odds of BMI status transition with normal to nor-
mal transition as the reference. Gender, age of puberty 
onset, personal smoking status, and maternal BMI were 
included as confounders. To evaluate whether the effect 
of DNAm was gender-specific, the model was further 
extended by including the interaction effect between gen-
der and DNAm at each CpG site. A p value < 0.05 after 
controlling false discovery rate (FDR) of 0.05 was consid-
ered as being statistically significant.
Further assessment in an independent cohort
The findings in the IoW cohort were tested in an inde-
pendent cohort, the Avon Longitudinal Study of Par-
ents and Children (ALSPAC). Details of the cohort were 
described elsewhere [40–42]. Women residing in the 
South West of England who were pregnant and expecting 
to deliver between April 1, 1991, and December 31, 1992, 
were eligible to be recruited. Of the 14,541 pregnant 
women eligible for recruitment, 13,761 were included 
in the study with 10,321 participants having their DNA 
sampled. DNAm was assessed using the Infinium 
HumanMethylation450 BeadChip. Please note that the 
study website contains details of all the data that is avail-
able through a fully searchable data dictionary and vari-
able search tool (http:// www. brist ol. ac. uk/ alspac/ resea 
rchers/ our- data/).
DNAm data from 1,018 offspring in the ALSPAC 
cohort were available at ages 7 and 15 or 17  years. The 
pre-processing of DNAm was performed by correcting 
for batch effects using the minfi package [32] and remov-
ing CpGs with detection p value ≥ 0.01. Samples were 
flagged that contained sex-mismatch based on X-chro-
mosome methylation. Proportions of the same six cell 
types were estimated. The batch- and cell type-adjusted 
DNAm was estimated as for the IoW cohort.
ZBMI transition of a child from ages 7 to 15 or 17 years 
was inferred in the same way as that in the IoW cohort. 
Those CpGs showing regression coefficients consist-
ent with those in the IoW cohort and a corresponding p 
value < 0.05 at marginally significant were treated as suc-
cessfully replicated CpGs.
Pathway analysis
The genes corresponding to the identified CpGs were 
annotated using the Illumina array manifest gene annota-
tions and SNIPPER (https:// csg. sph. umich. edu/ boehnke/
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snipper/) version 1.2, and the UCSC Genome Browser 
on Human Mar.2006 Assembly. ToppFun (https:// toppg 
ene. cchmc. org/ enric hment. jsp) was applied to detect 
functional enrichment of pathways and biological pro-
cesses using KEGG and REACTOME pathways and 
Gene Ontology (GO) biological processes. An adjusted 
p value < 0.05 after controlling FDR was considered as 
being statistically significant.
Biological relevance of identified CpGs
For CpG sites showing consistent associations with BMI 
status change between the IoW and ALSPAC cohorts, 
we examined their biological relevance by assessing the 
association of age 10 DNAm at a CpG site with expres-
sion of its mapped genes at age 26 years. Spearman’s rank 
correlation was used to assess the associations. Statistical 
significance was inferred at p value < 0.05.
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